Anavex Life Sciences Corp (AVXL)

[sliceanddice59]

I agree with you in that some of the poor efficacy of anti-amyloid compounds may relate to patients that were in a stage of the disease too far advanced to benefit. Some of these compounds may still be found useful, but I believe it will be in the context of a multimodality approach. I don't know of any complex diseases which are treated with a single medication. I don't anticipate a "magic bullet" for Alzheimer's or any other complex disease. However I continue to believe that A2-73 will play a central role in the armamentarium of medications that will be used for this and other neurodegenerative diseases. Positive results in the Rett trial will be widely noticed.